1. Home
  2. NEOG vs HROW Comparison

NEOG vs HROW Comparison

Compare NEOG & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neogen Corporation

NEOG

Neogen Corporation

HOLD

Current Price

$7.03

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$48.45

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEOG
HROW
Founded
1981
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
1989
N/A

Fundamental Metrics

Financial Performance
Metric
NEOG
HROW
Price
$7.03
$48.45
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$8.83
$68.86
AVG Volume (30 Days)
3.4M
562.9K
Earning Date
01-08-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$886,886,000.00
$250,042,000.00
Revenue This Year
N/A
$38.96
Revenue Next Year
$1.80
$43.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
47.83
52 Week Low
$3.87
$20.85
52 Week High
$13.41
$51.53

Technical Indicators

Market Signals
Indicator
NEOG
HROW
Relative Strength Index (RSI) 58.67 58.51
Support Level $7.01 $44.19
Resistance Level $7.29 $51.53
Average True Range (ATR) 0.25 2.31
MACD -0.03 -0.08
Stochastic Oscillator 41.19 62.95

Price Performance

Historical Comparison
NEOG
HROW

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: